EUVIMEDEUVIMED entdecken
Crossref

Residual Apolipoprotein B Elevation Despite PREVENT ‐Guided LDL ‐C Goal Attainment Among Adults Without Known ASCVD

Yanping Shi, Yuan Tang, Mengting Wang, Xu Zhu iD, Haifeng Zhang iD

Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11248-11258

DOI: 10.1111/dom.71329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 09.09.2026. Verfasst von Yanping Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical Unive…. Hauptthemen laut MEDLINE: Cholesterol, LDL, Atherosclerosis, Apolipoproteins B. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Gusu Health Personnel Training Project, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Low‐density lipoprotein cholesterol (LDL‐C) goal attainment is central to primary atherosclerotic cardiovascular disease (ASCVD) prevention, but LDL‐C may not fully reflect the burden of apolipoprotein B (ApoB)‐containing atherogenic particles. The prevalence and clinical correlates of residual ApoB elevation among adults who have attained PREVENT risk–stratified LDL‐C goals remain unclear.

Methods

This cross‐sectional study used data from the National Health and Nutrition Examination Survey (NHANES) 2005–2016 from adults aged 30–79 years without known ASCVD. The primary analytic sample included participants with 10‐year PREVENT‐ASCVD risk ≥ 3% who attained risk‐stratified LDL‐C goals. Residual ApoB elevation was defined as ApoB ≥ 90 mg/dL for PREVENT‐ASCVD risk 3% to < 10% and ≥ 70 mg/dL for risk ≥ 10%. Survey‐weighted analyses were used to estimate prevalence and identify factors associated with residual ApoB elevation.

Results

Among 3857 adults with PREVENT‐ASCVD risk ≥ 3%, 908 (23.5%) attained risk‐stratified LDL‐C goals. Of these, 128 had residual ApoB elevation, corresponding to a weighted prevalence of 17.7% (95% CI, 14.5%–21.4%). The prevalence was substantially higher among participants with triglycerides 150–400 mg/dL than among those with triglycerides < 150 mg/dL (43.6% vs. 4.3%; p < 0.001). In multivariable logistic regression, triglycerides of 150–400 mg/dL were strongly associated with residual ApoB elevation (adjusted OR, 15.87; 95% CI, 8.28–30.41; p < 0.001). Higher odds were also observed for PREVENT‐ASCVD risk ≥ 10%, obesity, metabolic syndrome and advanced cardiovascular‐kidney‐metabolic stages (CKM Stages 2–4). The association with triglycerides was consistent across exploratory subgroups and robust in sensitivity analyses.

Conclusions

Among U.S. adults without known ASCVD who attained PREVENT risk–stratified LDL‐C goals, residual ApoB elevation was common and strongly associated with triglyceride elevation. The prognostic and clinical significance of this discordant phenotype remains to be established.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesterol, LDLAtherosclerosisApolipoproteins BHumansMiddle AgedAdultFemaleMaleCross-Sectional StudiesAgedNutrition SurveysUnited StatesPrevalence

Stichwörter der Autor:innen

ASCVDLDL cholesterolNHANESPREVENTapolipoprotein Blipid discordancetriglycerides

Substanzen

Cholesterol, LDLApolipoproteins B

Autor:innen und Institutionen

  • Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
  • Department of Cardiology, The First Affiliated Hospital With Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
  • Department of Geriatrics, The First Affiliated Hospital With Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.

ORCID-Profile: Xu Zhu, Haifeng Zhang

Förderung

  • Gusu Health Personnel Training Project
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Project from Gusu School

Zitieren

APA

Shi, Y., Tang, Y., Wang, M., Zhu, X., & Zhang, H. (2026). Residual Apolipoprotein B Elevation Despite PREVENT ‐Guided LDL ‐C Goal Attainment Among Adults Without Known ASCVD. Diabetes, Obesity and Metabolism, 28(12), 11248-11258. https://doi.org/10.1111/dom.71329

Vancouver

Shi Y, Tang Y, Wang M, Zhu X, Zhang H. Residual Apolipoprotein B Elevation Despite PREVENT ‐Guided LDL ‐C Goal Attainment Among Adults Without Known ASCVD. Diabetes, Obesity and Metabolism. 2026;28(12):11248-11258. doi:10.1111/dom.71329

BibTeX
@article{Shi2026,
  author = {Shi, Yanping and Tang, Yuan and Wang, Mengting and Zhu, Xu and Zhang, Haifeng},
  title = {Residual Apolipoprotein B Elevation Despite PREVENT ‐Guided LDL ‐C Goal Attainment Among Adults Without Known ASCVD},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {12},
  pages = {11248--11258},
  doi = {10.1111/dom.71329}
}
Kostenlos starten →